New PDUFA legislation will provide the FDA with dedicated funds to increase its reviewer staff. This financial allocation aims to bolster the agency's capacity for dr-g and device reviews. Pharmaceutical trade groups have confirmed this development. The agreement is expected to improve the efficiency of regulatory processes. This funding is a significant step for the agency's operational capabilities.
Washington, D.C.
https://endpoints.news/new-pdufa-deal-sets-aside-fda-money-to-rehire-reviewers-lost-to-layoffs/